Mak qualified for his PhD in May 2018 under the supervision of Professor Eric Gowans, Dr Branka Grubor-Bauk and Dr Dan Wijesundara. His research focussed on the development of a DNA vaccine for the Hepatitis C virus (HCV).
The Viral Immunology Group aims to develop DNA vaccines that are capable of simultaneously eliciting both humoral immunity and cell-mediated immunity to HCV. Administration of these new vaccines will provide protection against HCV, and will help reduce the transmission of HCV infections worldwide.
2018: PhD, The University of Adelaide.
Thesis title: Novel DNA Vaccine Formulations Against Hepatitis C Virus
Scholarship: University of Adelaide full divisional scholarship
Mak also completed his Bachelor of Science (Biomedical Science) majoring in genetics, microbiology and immunology at the University of Adelaide. He followed this with a first class Honours degree in microbiology and immunology during which he worked on the analysis of immune responses to tissue-invasive parasitic worms.
2017: Domestic Travel Award (value $1000), 12th Annual Scientific Meeting of the Australian Centre for HIV and Hepatitis Virology (2017)
2015: School of Medicine Prize for Outstanding Poster Presentation, Florey Postgraduate Research Conference, University of Adelaide